Inherently poor survival of elderly patients with nasopharyngeal carcinoma

来源 :2015年北京放射肿瘤年会 | 被引量 : 0次 | 上传用户:liongliong456
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Background.The purpose of this study was to determine the features of the eldedy patient with nasopharyngeal carcinoma (NPC).Methods.The medical records of 212 patients with NPC, aged >65 years, and receiving radiotherapy were retrospectively reviewed.Comorbidity was rated using the Charlson Comorbidity Index (CCI).Results.Twenty-four patients (11.3%) scored >3 and 188 patients (88.7%) scored <3 rated by CCI.The median actuarial irradiated dose of the nasopharynx was 72 Gy (range, 20-94 Gy) with 87.3% patients receiving >70 Gy.0ne hundred fifty-four patients had stage Ⅲ/Ⅳ disease.The actuarial local control, cancer-specific survival (CSS), and overall survival (0S) rates at 5 years were 68.8%, 63.5%, and 47.0%, respectively.0n multivariate analysis, stage (hazard ratio [HR], 1.489;95% confidence interval [CI], 1.168-1.897;p =.001), the technique of radiotherapy (HR,0.674;95% CI, 0.476-0.953;p =.025), and anemia (HR, 3.081;95% CI,1.624-5.845;p =.001) were independent prognostic factors.Conclusion.The elderly patients with NPC may inherently predict poor outcomes.
其他文献
患者,女,83岁,2014年1月因"咳嗽、胸闷"就诊于当地医院,查体:体型偏瘦,呼吸动度两侧不对称,语颤左侧减弱,,左肺呼吸音减低,心律齐,各瓣膜听诊区未闻及杂音."高血压"病史10年,余无特殊.胸部CT显示,纵隔占位,最大截面7.8cm×11.4cm,边界不清,包绕升主动脉、肺动脉干,突入左肺野;纵隔内、双肺门、心包左侧壁、心包横膈区、左侧内乳区多发淋巴结肿大;双侧胸腔积液.影像诊断:巨大侵袭性
目的:探讨γ-体部立体定向放疗(stereotic body radiation therapy withγ-knife,γ-SBRT)配合热疗及替古奥治疗局部晚期胰腺癌疗效..方法:2012年6月-2013年4月,收治54例胰腺癌患者,30侧行γ-SBRT配合热疗,24例行γ-SBRT配合热疗及替吉奥治疗.结果:治疗后3个月总的有效率为79.6%(43/54).γ-SBRT配合热疗的1年生存率为
Background: In recent years, chemotherapy, radiotherapy, and targeted drugs have been respectively used in nasopharyngeal carcinoma.In our research, we combined all of them for better curative effects
会议
盐酸羟考酮缓释片作为一种新型的强阿片类镇痛药,镇痛效果确切、口服安全性高、不良反应轻微,持续应用可提高癌痛患者的生存质量,是临床治疗中重度癌痛的首选药物之一.针对盐酸羟考酮缓释片治疗癌痛的药理特点,近年国内外将其用于癌痛治疗过程中的剂量调整,取得了很好的效果.
Objective To evaluate concurrent chemotherapy for T4 classification nasopharyngeal carcinoma (NPC) treated by intensity-modulated radiotherapy (IMRT).Methods From July 2004 to June 2011,180 non-metast
会议
本研究主要是评价接受根治性切除和辅助化疗的pⅢA-N2期非小细胞肺癌(NSCLC)患者,进一步接受术后三维适形放疗(3DCRT)对生存和复发模式的影响.从2009.1.1到2013.5.31,所有患者均接受根治性肺叶切除的pⅢA-N2NSCLC患者在完成4周期以顺铂为基础的联合化疗后进行全面复查,未出现肿瘤复发转移的患者被随机分入术后放疗(PORT)组和对照组.入组≥2年的患者纳入本次分析.POR
分析Ⅳ期肺腺癌采用选择性放疗联合/或靶向治疗的疗效.分析本院2009年6月1日起,Ⅳ期肺腺癌接受肺原发病灶和关键转移病灶选择性放疗联合/或靶向治疗的患者共50例,其中单纯应用小分子靶向药物(表皮生长因子受体酪氨酸激酶抑制剂,EGFR-TKI)7例,单纯选择性放疗患者18例,选择性放疗联合EGFR-TKI25例.小分子靶向药物使用时间1~44月,中位时间14月.放疗方案为:体部伽马刀技术,70%等剂
Objective: To evaluate the long-term survival outcomes and toxicity of a larger series of patients with non-metastatic T4 classification nasopharyngeal carcinoma (NPC) treated with intensity-modulated
For patients with locoregionally advanced nasopharyngeal carcinoma (NPC), radiotherapy, chemotherapy and even targeted therapy are widely accepted treatments.These treatments, although they mostly ach